Preparing for Growth in Neurodegenerative Treatment Opportunities: How Clinical Teams can Best Position Study Design and Strategy to Reach Study Participants
October 28, 2022
Tags:
PPD’s Alberto Lledó, M.D., Ph.D., Christine Martino, MPM, John Hamlet, and Sabine Krofczik-Wilhelm, Ph.D. discuss clinical trial solutions to keep pace with the innovation in neurodegenerative diseases.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.
.svg)
